(407 days)
The "Panag" is a battery operated portable transcutaneous electrical nerve stimulator used to apply an electrical current through electrodes to a patient's skin for symptomatic pain relief. For the symptomatic relief of chronic intractable, post-traumatic and post-surgical pain.
The "Panag" is a battery operated portable transcutaneous electrical nerve stimulator used to apply an electrical current through electrodes to a patient's skin for symptomatic pain relief.
The provided text is a letter from the FDA regarding a 510(k) premarket notification for a medical device called "Panag." This document is a regulatory approval letter, not a study report. Therefore, it does not contain the information requested in your prompt regarding acceptance criteria, device performance, study details, or ground truth establishment.
The letter simply states that the FDA has reviewed the submission and determined that the device is "substantially equivalent" to legally marketed predicate devices. This means that the device is considered safe and effective because it is similar enough to existing devices that have already been cleared.
To answer your questions, I would need a different type of document, such as a clinical study report, a scientific publication, or a detailed product submission document that includes performance data and methodology.
§ 882.5890 Transcutaneous electrical nerve stimulator for pain relief.
(a)
Identification. A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain.(b)
Classification. Class II (performance standards).